N-(4-(3-acrylamidobenzamido)-2-methylphenyl)-4-(2,6-dichlorobenzamido)-1H-pyrazole-3-carboxamide 2,2,2-trifluoroacetate

ID: ALA4535164

PubChem CID: 155547828

Max Phase: Preclinical

Molecular Formula: C30H23Cl2F3N6O6

Molecular Weight: 577.43

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=CC(=O)Nc1cccc(C(=O)Nc2ccc(NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cccc3Cl)c(C)c2)c1.O=C(O)C(F)(F)F

Standard InChI:  InChI=1S/C28H22Cl2N6O4.C2HF3O2/c1-3-23(37)32-17-7-4-6-16(13-17)26(38)33-18-10-11-21(15(2)12-18)34-28(40)25-22(14-31-36-25)35-27(39)24-19(29)8-5-9-20(24)30;3-2(4,5)1(6)7/h3-14H,1H2,2H3,(H,31,36)(H,32,37)(H,33,38)(H,34,40)(H,35,39);(H,6,7)

Standard InChI Key:  JMDFPPOMIAKKAZ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 47 49  0  0  0  0  0  0  0  0999 V2000
    8.5506   -6.1616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2583   -5.7530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8429   -5.7530    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.5506   -6.9788    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.8407   -6.5661    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.9660   -6.1616    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2583   -4.9358    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6621   -4.5152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4793   -4.5152    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2535   -3.8075    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2535   -5.2229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4372   -5.2201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0286   -5.9270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4373   -6.6357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2587   -6.6331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6635   -5.9256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0299   -4.5117    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.4807   -5.9222    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.1136   -4.5152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8878   -3.8097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7050   -3.8075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9555   -3.0296    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.2931   -2.5509    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6333   -3.0331    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9308   -4.5152    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7050   -5.2229    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3394   -3.8075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1555   -3.8102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5640   -3.1034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1554   -2.3947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3340   -2.3973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9291   -3.1048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5630   -1.6864    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.3802   -1.6853    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7879   -0.9771    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.7898   -2.3925    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3817   -3.0985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7905   -3.8051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6086   -3.8045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0161   -3.0913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6049   -2.3875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8333   -3.0873    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.2453   -3.7930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0625   -3.7890    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.8401   -4.5027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2522   -5.2084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5628   -4.5187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  1  4  1  0
  1  5  1  0
  2  6  1  0
  2  7  2  0
  8  9  1  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 12 17  1  0
 16 18  1  0
  9 20  1  0
 21 19  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 20  2  0
 19 25  1  0
 19 26  2  0
 25 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 30 33  1  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
 41 36  1  0
 40 42  1  0
 42 43  1  0
 43 44  2  0
 43 45  1  0
 45 46  2  0
 28 47  1  0
M  END

Associated Targets(Human)

CDK14 Tchem Cyclin-dependent kinase 14/Cyclin-Y (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 577.43Molecular Weight (Monoisotopic): 576.1080AlogP: 5.91#Rotatable Bonds: 8
Polar Surface Area: 145.08Molecular Species: NEUTRALHBA: 5HBD: 5
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.30CX Basic pKa: CX LogP: 5.65CX LogD: 5.65
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.17Np Likeness Score: -1.53

References

1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS..  (2019)  Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14.,  29  (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024]

Source